We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

118 hedge funds and large institutions have $215M invested in Surmodics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

2% less funds holding

Funds holding: 120118 (-2)

8% less capital invested

Capital invested by funds: $234M → $215M (-$19.7M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
118
Holders Change
-2
Holders Change %
-1.67%
% of All Funds
3.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
47
Reduced
43
Closed
6
Calls
Puts
Net Calls
Net Calls Change

SRDX Hedge Fund Activity: Q1 2016 in Review

118 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2016, worth a combined $215M — down 8.4% from $234M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SRDX and 4 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 47 added.

The largest buyer was Wellington Management Group, adding an estimated $2.44M. The largest seller was JP Morgan Chase, cutting an estimated $1.71M.

  • 118 institutional investors held Surmodics (SRDX) as of Q1 2016, down from 120 in Q4 2015.
  • Funds reported $215M of Surmodics stock for Q1 2016, down 8.4% quarter-over-quarter.
  • 4 funds opened new Surmodics positions in Q1 2016 and 6 closed out, a net change of -2 holders.
  • The largest Surmodics buyer in Q1 2016 was Wellington Management Group, an estimated $2.44M added.
  • The largest Surmodics seller in Q1 2016 was JP Morgan Chase, an estimated $1.71M sold.

Based on aggregated 13F filings for Q1 2016.